PULMONARY SARCOIDOSIS
Clinical trials for PULMONARY SARCOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new PULMONARY SARCOIDOSIS trials appear
Sign up with your email to follow new studies for PULMONARY SARCOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new infusion drug tame lung inflammation and cut steroid use?
Disease control ENROLLING_BY_INVITATIONThis trial is investigating whether an experimental drug called XTMAB-16 can safely control pulmonary sarcoidosis over the long term. The study includes people who have already completed a previous XTMAB-16 trial and are on a stable steroid dose. Researchers are monitoring side e…
Matched conditions: PULMONARY SARCOIDOSIS
Phase: PHASE2 • Sponsor: Xentria, Inc. • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Study reveals: sticking to sarcoidosis meds may improve outcomes
Knowledge-focused OngoingThis study looks at how well people with sarcoidosis take their prescribed medicines and whether that affects their disease. Researchers will follow 150 adults in Maryland and D.C. for one year, tracking lung function, symptoms, and hospital visits. The goal is to find ways to he…
Matched conditions: PULMONARY SARCOIDOSIS
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC